Maze lands new partner for Pompe drug, after Sanofi pact came apart

[cafead]

via Biotechnology startup Maze Therapeutics has licensed a Pompe disease drug to Shionogi, five months after a challenge from the Federal Trade Commission caused Sanofi to back out of a similar deal for the same medicine.

article source